BI-1206
Product Specifications
Target
Immunology/Inflammation related, Others
Related Pathways
Immunology/Inflammation, Others
Bioactivity
BI-1206 is a recombinant antagonistic human monoclonal antibody targeting FcγRIIB (CD32B) . It inhibits CD20 internalization induced by Rituximab, whether used alone or in combination with drugs such as Ibrutinib, Venetoclax, and CHOP. BI-1206 can enhance or restore the activity of Rituximab or other anti-CD20 monoclonal antibodies and demonstrates cytolytic activity against malignant B cells. BI-1206 is applicable in research on cancers such as mantle cell lymphoma (MCL) .
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6462762-01 0.1 mL
AMPK beta, NT (5'-AMP-activated Protein Kinase Subunit beta-1, AMPK Subunit beta-1, AMPK, PRKAB1) (MaxLight 550)
Sign In for Pricing
View Details MBS6462762-02 5x 0.1 mL
AMPK beta, NT (5'-AMP-activated Protein Kinase Subunit beta-1, AMPK Subunit beta-1, AMPK, PRKAB1) (MaxLight 550)
Sign In for Pricing
View Details